Takehisa Araki Selected Research

Benzodiazepines

2/2002

[A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takehisa Araki Research Topics

Disease

2	Parkinson Disease (Parkinson's Disease) 07/2014 - 02/2002
1	Multiple System Atrophy 01/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 12/2020
1	Herpes Zoster 12/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2014
1	Dermatomyositis (Dermatopolymyositis) 01/2014
1	Dyslexia (Alexia) 04/2006
1	Agraphia (Dysgraphia) 04/2006
1	Fever (Fevers) 02/2002
1	Hypothyroidism 02/2002
1	Muscle Rigidity 02/2002
1	Neuroleptic Malignant Syndrome 02/2002
1	Seizures (Absence Seizure) 02/2002

Drug/Important Bio-Agent (IBA)

2	SteroidsIBA 01/2014 - 04/2006
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2020
1	ASP2151IBA 12/2020
1	polyglutamineIBA 07/2014
1	Prednisolone (Predate)FDA LinkGeneric 01/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	GlucocorticoidsIBA 01/2014
1	Methylprednisolone FDA LinkGeneric 01/2014
1	Alanine Transaminase (SGPT)IBA 01/2014
1	Antidepressive Agents (Antidepressants)IBA 02/2002
1	Amitriptyline (Elavil)FDA LinkGeneric 02/2002
1	Thyroid HormonesIBA 02/2002
1	Dantrolene (Dantrium)FDA LinkGeneric 02/2002
1	etizolamIBA 02/2002
1	Bromocriptine (Parlodel)FDA LinkGeneric 02/2002
1	BenzodiazepinesIBA 02/2002
1	Antiparkinson Agents (Antiparkinsonian Agents)IBA 02/2002

Therapy/Procedure

2	Therapeutics 01/2014 - 04/2006
1	Injections 01/2014